BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28316008)

  • 1. Cytogenetic analysis of metaplastic squamous cell carcinoma of the breast inter- and intratumoral heterogeneity.
    Oikawa M; Igawa A; Taguchi K; Baba K; Ishida M; Akiyoshi S; Yano H; Nagayasu T; Ohno S; Tokunaga E
    Breast Cancer; 2017 Nov; 24(6):733-741. PubMed ID: 28316008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
    Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
    Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization.
    Aubele M; Mattis A; Zitzelsberger H; Walch A; Kremer M; Hutzler P; Höfler H; Werner M
    Cancer Genet Cytogenet; 1999 Apr; 110(2):94-102. PubMed ID: 10214356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma.
    Lien HC; Hsu CL; Lu YS; Chen TW; Chen IC; Li YC; Huang CS; Cheng AL; Lin CH
    Breast Cancer Res; 2023 Jan; 25(1):11. PubMed ID: 36707876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.
    Hawthorn L; Luce J; Stein L; Rothschild J
    BMC Cancer; 2010 Aug; 10():460. PubMed ID: 20799942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast.
    Bae JS; Choi JS; Baik SH; Park WC; Song BJ; Kim JS; Lim Y; Jung SS
    World J Surg Oncol; 2010 Apr; 8():32. PubMed ID: 20409316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast.
    Liao S; Desouki MM; Gaile DP; Shepherd L; Nowak NJ; Conroy J; Barry WT; Geradts J
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1067-78. PubMed ID: 22887771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution.
    Buerger H; Mommers EC; Littmann R; Simon R; Diallo R; Poremba C; Dockhorn-Dworniczak B; van Diest PJ; Boecker W
    J Pathol; 2001 Jun; 194(2):165-70. PubMed ID: 11400144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
    Joosse SA; Brandwijk KI; Devilee P; Wesseling J; Hogervorst FB; Verhoef S; Nederlof PM
    Breast Cancer Res Treat; 2012 Apr; 132(2):379-89. PubMed ID: 20614180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component.
    Avigdor BE; Beierl K; Gocke CD; Zabransky DJ; Cravero K; Kyker-Snowman K; Button B; Chu D; Croessmann S; Cochran RL; Connolly RM; Park BH; Wheelan SJ; Cimino-Mathews A
    Clin Cancer Res; 2017 Aug; 23(16):4875-4884. PubMed ID: 28424200
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative genomic hybridization (CGH) analysis of chromosomal aberrations in Iranian patients with invasive ductal carcinoma breast cancer.
    Ghaffari SR; Sabokbar T; Pour PN; Dastan J; Mehrkhani F; Shoraka S; Mohagheghi MA; Tirgari F; Mosavi-Jarrahi A
    Asian Pac J Cancer Prev; 2008; 9(1):66-70. PubMed ID: 18439077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
    Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
    J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.
    Lee E; Moon JW; Wang X; Kim C; Li S; Shin BK; Jung W; Kim HK; Kim HK; Lee JY
    Hum Pathol; 2015 Aug; 46(8):1111-20. PubMed ID: 26003479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metaplastic carcinoma of the breast: p53 analysis identified the same point mutation in the three histologic components.
    Wang X; Mori I; Tang W; Yang Q; Nakamura M; Nakamura Y; Sato M; Sakurai T; Kennichi K
    Mod Pathol; 2001 Nov; 14(11):1183-6. PubMed ID: 11706082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast.
    Grenier J; Soria JC; Mathieu MC; Andre F; Abdelmoula S; Velasco V; Morat L; Besse B; Dunant A; Spielmann M; Delaloge S
    Anticancer Res; 2007; 27(1B):547-55. PubMed ID: 17348440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis.
    Boelens MC; Kok K; van der Vlies P; van der Vries G; Sietsma H; Timens W; Postma DS; Groen HJ; van den Berg A
    Lung Cancer; 2009 Dec; 66(3):372-8. PubMed ID: 19324446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.
    Wang C; Iakovlev VV; Wong V; Leung S; Warren K; Iakovleva G; Arneson NC; Pintilie M; Miller N; Youngson B; McCready DR; Done SJ
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1091-101. PubMed ID: 19760610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer.
    Kikuchi-Koike R; Nagasaka K; Tsuda H; Ishii Y; Sakamoto M; Kikuchi Y; Fukui S; Miyagawa Y; Hiraike H; Kobayashi T; Kinoshita T; Kanai Y; Shibata T; Imoto I; Inazawa J; Matsubara O; Ayabe T
    BMC Cancer; 2019 May; 19(1):521. PubMed ID: 31146704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.
    Jones C; Nonni AV; Fulford L; Merrett S; Chaggar R; Eusebi V; Lakhani SR
    Br J Cancer; 2001 Aug; 85(3):422-7. PubMed ID: 11487275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization.
    Gao Y; Niu Y; Wang X; Wei L; Lu S
    J Mol Med (Berl); 2009 Feb; 87(2):145-52. PubMed ID: 18936904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.